| Chelsea Whitmire, MA, CCC-SLP | |
|
807b Magnolia Dr, Aberdeen, NC 28315-2205 | |
| (419) 889-0435 | |
| Not Available |
| Full Name | Chelsea Whitmire |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 807b Magnolia Dr, Aberdeen, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558719120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60641307 (Washington) | Primary |
| Provider Name | Paragon Outpatient Rehabilitation Services, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1871867325 PECOS PAC ID: 8022272848 Enrollment ID: O20160728001716 |
News Archive
Brain State Technologies announces the presentation of a study that describes how use of a wearable neurotechnology device by military personnel could improve sleep and thereby lower the risk of developing post traumatic stress disorder (PTSD).
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Two studies by researchers at the University of Chicago show how the bacteria that cause the plague manage to outsmart the immune system and how, by slightly altering one of the microbe's tools, the researchers produced what may be the first safe and effective vaccine.
Scientists are narrowing in on checklists of both errant genes and the environmental factors that could trigger those genes to more accurately assess type 1 diabetes risk and help children and their families avoid it.
› Verified 5 days ago
| Provider Name | Aegis Group Practice Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093389751 PECOS PAC ID: 5193036432 Enrollment ID: O20210621000546 |
News Archive
Brain State Technologies announces the presentation of a study that describes how use of a wearable neurotechnology device by military personnel could improve sleep and thereby lower the risk of developing post traumatic stress disorder (PTSD).
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Two studies by researchers at the University of Chicago show how the bacteria that cause the plague manage to outsmart the immune system and how, by slightly altering one of the microbe's tools, the researchers produced what may be the first safe and effective vaccine.
Scientists are narrowing in on checklists of both errant genes and the environmental factors that could trigger those genes to more accurately assess type 1 diabetes risk and help children and their families avoid it.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Whitmire, MA, CCC-SLP 807b Magnolia Dr, Aberdeen, NC 28315-2205 Ph: (419) 889-0435 | Chelsea Whitmire, MA, CCC-SLP 807b Magnolia Dr, Aberdeen, NC 28315-2205 Ph: (419) 889-0435 |
News Archive
Brain State Technologies announces the presentation of a study that describes how use of a wearable neurotechnology device by military personnel could improve sleep and thereby lower the risk of developing post traumatic stress disorder (PTSD).
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Two studies by researchers at the University of Chicago show how the bacteria that cause the plague manage to outsmart the immune system and how, by slightly altering one of the microbe's tools, the researchers produced what may be the first safe and effective vaccine.
Scientists are narrowing in on checklists of both errant genes and the environmental factors that could trigger those genes to more accurately assess type 1 diabetes risk and help children and their families avoid it.
› Verified 5 days ago